Results 21 to 30 of about 199,364 (50)

Demographics and Immunotherapy Efficacy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials

Liver Cancer
Introduction: Immune checkpoint inhibitors (ICIs) are fundamental in treating advanced hepatocellular carcinoma (HCC). Considering previous reports implied varied responses among patient subgroups, such as patients with different hepatitis ...
Yu-Yun Shao, Andrei R. Akhmetzhanov
doaj   +1 more source

The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma

Tumor Biology, 2017
Lung adenocarcinoma remains to be a high-mortality disease with few effective prognostic biomarkers. Novel biomarkers are urgently demanded to supplement the current prognostic biomarkers.
Mao Qixing, Xu Juqing, Wang Yajing, Dong Gaochao, Xia Wenjie, Shi Run, Wang Anpeng, Xu Lin, Jiang Feng, Wang Jun   +9 more
doaj   +1 more source

Trend of Death and Years of Life Lost Caused by Lung Cancer in Handan, 2017-2023

Chinese Journal of Lung Cancer
Background and objective Lung cancer ranks as the foremost cause of cancer-related deaths in China, significantly undermining population health and longevity.
Nianzhen FANG, Yang ZHAO, Yang YANG
doaj   +1 more source

Comparison of efficacy of Retzius-sparing radical prostatectomy versus standard radical prostatectomy in the treatment of prostate cancer: a systematic review and meta-analysis

Frontiers in Oncology
ObjectiveTo compare the efficacy of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) versus standard robot-assisted radical prostatectomy (S-RARP) in treating prostate cancer patients regarding urinary continence (UC) recovery, oncological ...
Weilun Gong, Junfeng Yan, Yilun Cui, Duojie Zhang, Yinfeng Ma   +4 more
doaj   +1 more source

Clinical Characteristics, MAML2 Gene Rearrangement and Prognosis 
of Pulmonary Mucoepidermoid Carcinoma

Chinese Journal of Lung Cancer
Background and objective Primary pulmonary mucoepidermoid carcinoma (PMEC) is an exceedingly rare malignancy originating from bronchial submucosal glands, accounting for
Jianrong BAI, Meng YAN, Lingchuan GUO, Zhe LEI, Weishuo LIU, Zigui ZOU, Jiao LI, Yushuang ZHENG   +7 more
doaj   +1 more source

AI-powered advances in type II endometrial cancer: global trends and African contexts

Frontiers in Oncology
IntroductionThe advent of artificial intelligence (AI) in oncology has opened new avenues for enhancing the diagnosis, treatment, and prognosis of type II endometrial cancers (ECs), which account for the majority of EC-related deaths globally.
Thulo Molefi, Thulo Molefi, Thulo Molefi, Lloyd Mabonga, Rodney Hull, Motshedisi Sebitloane, Zodwa Dlamini   +6 more
doaj   +1 more source

Novel ultrasound features and diagnostic clues of gastric-type endocervical adenocarcinoma: a case series

Frontiers in Oncology
BackgroundGastric-type endocervical adenocarcinoma (G-EAC) is a rare and aggressive subtype of cervical cancer which is not associated with human papillomavirus (HPV) infection but has poor prognosis because of its high invasiveness and resistance to ...
Liwen Yang, Yangyang Wang, Jian Cai, Ying Xiong, Juan Li, Qi Zhou, Nan Ye, Hua Lai, Tianjiao Liu, Liuying Zhou   +9 more
doaj   +1 more source

Comparative study of total-body PET and PET/MR in the diagnosis of liver metastases

Frontiers in Oncology
ObjectiveTo compare the diagnostic differences between total-body PET/CT (positron emission tomography/computed tomography) and PET/MR (positron emission tomography/magnetic resonance) in detecting liver metastases.MethodsThe study analyzed data from ...
Cao Junxia, Xuanyuan Yirui, You Yang, Zhang Weifeng, Xuan Ang   +4 more
doaj   +1 more source

Immunological features of various molecular subtypes of cervical cancer and their prognostic implications in the context of disulfidptosis

Frontiers in Oncology
ObjectiveCervical cancer ranks among the most prevalent malignancies impacting women globally. Disulfidptosis represents a recently identified pathway of cellular demise, although its role in the context of cervical cancer is not well elucidated.
Yadan Yao, Xiaomin Yang, Yuanxin Fu, Yinmin Zhang   +3 more
doaj   +1 more source

Surgical and Oncological Outcomes of Minimally Invasive Left Pancreatectomy for Pancreatic Cancer: Robotic vs. Laparoscopic Approach

Current Oncology
Objective: This study compares the surgical and oncological outcomes of minimally invasive robotic (RLP) and laparoscopic (LLP) left pancreatectomy in pancreatic cancer (PC) patients.
Matteo De Pastena, Gabriella Lionetto, Salvatore Paiella, Martina Maruccio, Federico Faustini, Elisa Venturini, Antonio Pea, Fabio Casciani, Giuseppe Malleo, Alessandro Esposito   +9 more
doaj   +1 more source